These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 7350025)

  • 1. Altered drug metabolism and elevated serum bile acids in liver disease: a unified pharmacokinetic explanation.
    Gilmore IT; Hofmann AF
    Gastroenterology; 1980 Jan; 78(1):177-9. PubMed ID: 7350025
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bile acids in the liver and serum in various liver diseases].
    Greim H; Czygan P
    Verh Dtsch Ges Inn Med; 1974; 80():443-5. PubMed ID: 4454580
    [No Abstract]   [Full Text] [Related]  

  • 3. [Heterogenicity of liver parenchyma cells].
    Van Steenbergen W
    Acta Clin Belg; 1985; 40(6):376-87. PubMed ID: 3913260
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug administration in hepatic disease.
    Williams RL
    N Engl J Med; 1983 Dec; 309(26):1616-22. PubMed ID: 6358891
    [No Abstract]   [Full Text] [Related]  

  • 5. Clearance by the liver: current concepts in understanding the hepatic disposition of drugs.
    Larrey D; Branch RA
    Semin Liver Dis; 1983 Nov; 3(4):285-97. PubMed ID: 6359424
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug metabolism and liver disease in India.
    Narang AP; Kaur U; Bambery P
    Drug Metab Rev; 1991; 23(1-2):65-81. PubMed ID: 1868778
    [No Abstract]   [Full Text] [Related]  

  • 7. Determinants of serum bile acids in chronic liver disease.
    Paré P; Hoefs JC; Ashcavai M
    Gastroenterology; 1981 Nov; 81(5):959-64. PubMed ID: 7286574
    [No Abstract]   [Full Text] [Related]  

  • 8. [Side effects of drugs--predictable hazards for patients with liver disease].
    Baumgarten R
    Z Arztl Fortbild (Jena); 1983; 77(9):373-5. PubMed ID: 6880279
    [No Abstract]   [Full Text] [Related]  

  • 9. Biliary excretion of drugs and other xenobiotics.
    Levine WG
    Prog Drug Res; 1981; 25():361-420. PubMed ID: 6273968
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of liver disease on drug pharmacokinetics].
    Su CY
    Sheng Li Ke Xue Jin Zhan; 1983 Jul; 14(3):238-42. PubMed ID: 6648457
    [No Abstract]   [Full Text] [Related]  

  • 11. [Physiopathology of bile acids].
    Rodriguez Garay EA; Del Rosario Spetale M
    Medicina (B Aires); 1971; 31(4):343-56. PubMed ID: 4942878
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metabolism of drugs in the liver and disease].
    Sonne J; Døssing M; Loft S
    Ugeskr Laeger; 1988 Jan; 150(4):204-9. PubMed ID: 3376323
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
    O'Brien SM; Campbell GR; Burke AF; Maguire OC; Rowlands BJ; FitzGerald MX; Hegarty JE
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):477-83. PubMed ID: 8804877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dose adaptation of drugs for liver patients using a simple risk classification].
    Zysset T; Bircher J
    Internist (Berl); 1983 Mar; 24(3):151-61. PubMed ID: 6347941
    [No Abstract]   [Full Text] [Related]  

  • 15. [What information is gained from measuring serum bile acids].
    Poupon RY
    Gastroenterol Clin Biol; 1981; 5(8-9):769-71. PubMed ID: 7297813
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in drug kinetics in liver diseases and their importance in rational pharmacotherapy].
    Danysz A
    Pol Tyg Lek; 1977 Dec; 32(52):2057-60. PubMed ID: 604977
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatopathies and drugs].
    González Macias J; De Castro del Pozo S
    Rev Esp Enferm Apar Dig; 1974; 44(2):175-86. PubMed ID: 4418081
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug kinetics in liver disease].
    Saudek F
    Cas Lek Cesk; 1984 Feb; 123(7):181-5. PubMed ID: 6697366
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metabolism of bile acids in liver diseases].
    Lutz W; Szeszko A
    Pol Tyg Lek; 1979 Oct; 34(43):1679-82. PubMed ID: 514883
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic first-pass metabolism in liver disease.
    Blaschke TF; Rubin PC
    Clin Pharmacokinet; 1979; 4(6):423-32. PubMed ID: 391462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.